Cov Baxter International Inc (NYSE: Npuas) tshaj tawm spinning tawm nws lub raum Kev Kho Mob thiab Kev Kho Mob Kho Mob thoob ntiaj teb kev lag luam rau hauv kev ywj pheej, laj luam pej xeem lag.
Lub tuam txhab kho mob raum tshiab yuav tau txais txiaj ntsig los ntawm nws cov khoom lag luam uas twb muaj lawm, muaj ntau yam hneev taw, kev ua lag luam, thiab kev pabcuam uas txhawb nqa nws cov kev kho mob xa hauv tsev, chaw kho mob, thiab chav saib xyuas mob hnyav.
Related: Baxter Q3 Performance underwhelms Investors, FY22 Kev taw qhia Lags pom zoo.
Kev lag luam yuav ua haujlwm hauv cov lag luam lag luam uas muaj kwv yees li $ 15 nphom, kwv yees tias yuav loj hlob ntawm 3% mus rau 4% ntawm qhov sib xyaw ua ke txhua xyoo hauv peb lub xyoos tom ntej.
Hauv xyoo 2021, kev muag khoom rau cov lag luam no muaj kwv yees li $ 5 nphom thoob ntiaj teb.
Raws li cov qauv tsim, suav nrog Hillrom zoo li nws tau muaj rau tag nrho lub xyoo, 2021 kev muag khoom txhua xyoo thoob plaws cov lag luam no (tsis suav nrog Kev Kho Mob Raum thiab Kev Kho Mob) yog kwv yees li $ 11 billion. Baxter tseem yuav coj los ntawm CEO Joe Almeida.
Baxter tab tom nrhiav lwm txoj hauv kev rau BioPharma Solutions (BPS) kev lag luam, suav nrog kev muag khoom lossis lwm yam kev xaiv sib cais. BPS muaj kev cog lus tsim kev pabcuam rau cov chaw muag tshuaj thiab biotech kev lag luam.
Baxter cia siab tias yuav ua kom tiav cov lus pom zoo hauv 12 txog 18 lub hlis.
Nqe Nqis: BAX shares tau nqis 6.49% ntawm $ 49.15 ntawm daim tshev kawg rau hnub Friday.
Saib ntxiv ntawm Benzinga
Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.
© 2023 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.
Tau qhov twg los: https://finance.yahoo.com/news/baxter-plans-divesting-renal-care-183337780.html